Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 11.6% in First Three Quarters of 2023

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 1.8 billion yuan in the first three quarters of 2023, up 11.6% year-on-year.

Meanwhile, the company posted 5.9 billion yuan in revenue, up 19.9% year-on-year.

At the end of the reporting period, it had 31.9 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 6.6%.